Fagron Extends Its Reach with Acquisition of Euro OTC & Audor Pharma

Deal News | Jan 27, 2025 | Legal Community Germany

Fagron Extends Its Reach with Acquisition of Euro OTC & Audor Pharma

Fagron, an established global player in the pharmaceutical formulations industry, has strategically acquired Euro OTC & Audor Pharma to bolster its market position in Germany. This acquisition, facilitated by legal advisers Baker McKenzie, is set to consolidate Fagron's standing as the second-largest entity in the industry within Germany. Euro OTC & Audor Pharma, based in Bönen, is a significant supplier of pharmaceutical raw materials and services to both German and international markets. The integration process is projected to span two years, during which synergies are anticipated to develop through enhanced scale and deeper customer engagement. The legal team, led by Dr. Richard Stefanink from Baker McKenzie, provided vital support to Fagron during this transaction, which marks the first collaboration with the firm. Fagron's acquisition strategy aims to strengthen its operational footprint in over 40 countries, as it continues to produce high-quality pharmaceutical products.

Sectors

  • Pharmaceuticals
  • Legal Advisory

Geography

  • Germany – The acquisition takes place within Germany, and Fagron aims to consolidate its position in the German pharmaceutical market.
  • International – Fagron operates globally, supplying products to over 40 countries, and this acquisition further supports its international expansion strategy.

Industry

  • Pharmaceuticals – The article revolves around the pharmaceutical industry, specifically focusing on the acquisition of Euro OTC & Audor Pharma by Fagron, a company that supplies pharmaceutical raw materials.
  • Legal Advisory – This industry is highlighted through the involvement of Baker McKenzie, a law firm providing legal advisory services for the transaction.

Financials

    Participants

    NameRoleTypeDescription
    FagronAcquiring CompanyCompanyAn international market operator in pharmaceutical formulations aiming to strengthen its presence in Germany through acquisitions.
    Euro OTC & Audor Pharma GmbHTarget CompanyCompanyA medium-sized company based in Bönen, Germany, supplying pharmaceutical raw materials and serving both the German and international markets.
    Baker McKenzieLegal AdvisorCompanyA global law firm advising Fagron on the acquisition, ensuring a smooth transaction.
    Dr. Richard StefaninkLead PartnerPersonCorporate/M&A Partner at Baker McKenzie, leading the legal advisory team for this acquisition.
    Michal DillenGlobal Business Development ManagerPersonRepresents Fagron's interests and commented on the transaction process facilitated by Baker McKenzie.